title: Combining molecular targeted agents with radiation therapy for malignant gliomas.
abstract: The expansion in understanding the molecular biology that characterizes cancer cells has led to the rapid development of new agents to target important molecular pathways associated with aberrant activation or suppression of cellular signal transduction pathways involved in gliomagenesis, including epidermal growth factor receptor, vascular endothelial growth factor receptor, mammalian target of rapamycin, and integrins signaling pathways. The use of antiangiogenic agent bevacizumab, epidermal growth factor receptor tyrosine kinase inhibitors gefitinib and erlotinib, mammalian target of rapamycin inhibitors temsirolimus and everolimus, and integrin inhibitor cilengitide, in combination with radiation therapy, has been supported by encouraging preclinical data, resulting in a rapid translation into clinical trials. Currently, the majority of published clinical studies on the use of these agents in combination with radiation and cytotoxic therapies have shown only modest survival benefits at best. Tumor heterogeneity and genetic instability may, at least in part, explain the poor results observed with a single-target approach. Much remains to be learned regarding the optimal combination of targeted agents with conventional chemoradiation, including the use of multipathways-targeted therapies, the selection of patients who may benefit from combined treatments based on molecular biomarkers, and the verification of effective blockade of signaling pathways.
authors: Department of Radiation Oncology, Sant'Andrea Hospital, University Sapienza, Rome, Italy.
authors: Claudia
authors: C
authors: Scaringi
authors: Riccardo Maurizi
authors: RM
authors: Enrici
authors: Giuseppe
authors: G
authors: Minniti
keywords: glioblastoma; high-grade glioma; radiation therapy; targeted therapy; temozolomide
references: Acta Biochim Biophys Sin (Shanghai). 2011 Apr;43(4):292-300
references: 21367753
references: J Cell Sci Suppl. 1985;3:161-72
references: 3011820
references: Proc Natl Acad Sci U S A. 1987 Oct;84(19):6899-903
references: 3477813
references: J Neurosurg. 2012 Feb;116(2):341-5
references: 22035272
references: Cancer Res. 1999 Jul 15;59(14):3374-8
references: 10416597
references: N Engl J Med. 2008 Jul 24;359(4):378-90
references: 18650514
references: J Clin Oncol. 2009 Oct 1;27(28):4733-40
references: 19720927
references: Int J Oncol. 2011 Jul;39(1):271-8
references: 21537841
references: Mol Cancer Ther. 2008 Oct;7(10):3129-40
references: 18852116
references: Neurosci Lett. 2010 Jul 12;478(3):165-70
references: 20470863
references: Transl Oncol. 2008 Dec;1(4):195-201
references: 19043530
references: Arch Biochem Biophys. 2010 Oct 15;502(2):89-95
references: 20650261
references: Anticancer Res. 2009 Dec;29(12):5171-84
references: 20044633
references: J Clin Oncol. 2010 Jun 1;28(16):2712-8
references: 20439646
references: Clin Adv Hematol Oncol. 2012 Apr;10(4):240-6
references: 22706484
references: J Clin Oncol. 2008 Dec 1;26(34):5610-7
references: 18981465
references: Adv Ther. 2011 Apr;28(4):334-40
references: 21432029
references: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14765-70
references: 8962129
references: Eur J Cancer. 2012 Jul;48(10):1434-42
references: 22119354
references: Cancer Chemother Pharmacol. 2004 Feb;53(2):133-40
references: 14593497
references: Clin Cancer Res. 2005 Sep 1;11(17):6270-9
references: 16144931
references: Brain Pathol. 2003 Apr;13(2):133-43
references: 12744467
references: Cancer Res. 2002 Jan 1;62(1):200-7
references: 11782378
references: Clin Cancer Res. 2002 Oct;8(10):3250-8
references: 12374696
references: Clin Cancer Res. 2007 Jun 1;13(11):3395-402
references: 17545548
references: Br J Cancer. 2007 Apr 10;96(7):1047-51
references: 17353924
references: Lancet. 2007 Dec 22;370(9605):2103-11
references: 18156031
references: J Neurooncol. 2011 Jun;103(2):325-32
references: 20821342
references: Int J Radiat Biol. 2007 Nov-Dec;83(11-12):743-51
references: 17852562
references: Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):993-1001
references: 17967517
references: N Engl J Med. 2006 Dec 14;355(24):2542-50
references: 17167137
references: N Engl J Med. 2004 Jun 3;350(23):2335-42
references: 15175435
references: Cancer Res. 2005 Jun 15;65(12):5374-9
references: 15958586
references: Cancer Cell. 2004 Dec;6(6):553-63
references: 15607960
references: Mol Cancer Ther. 2008 Jun;7(6):1569-78
references: 18566227
references: Genome Biol. 2007;8(5):215
references: 17543136
references: J Clin Oncol. 2009 Feb 1;27(4):579-84
references: 19075262
references: Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):85-90
references: 20137866
references: Clin Cancer Res. 2009 Jan 15;15(2):701-7
references: 19147777
references: Biochem J. 1999 Dec 1;344 Pt 2:427-31
references: 10567225
references: Drugs. 2013 Mar;73(4):315-25
references: 23440867
references: BMC Cancer. 2006 Dec 11;6:285
references: 17156477
references: Br J Cancer. 2011 May 24;104(11):1691-6
references: 21540865
references: Anticancer Res. 2003 Sep-Oct;23(5A):3869-76
references: 14666690
references: Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1454-9
references: 15817350
references: Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):353-7
references: 15380566
references: Cell Cycle. 2013 Feb 1;12(3):491-500
references: 23324350
references: Semin Oncol. 2006 Aug;33(4):369-85
references: 16890793
references: J Clin Oncol. 2008 Feb 20;26(6):919-24
references: 18281665
references: PLoS One. 2012;7(6):e38231
references: 22701615
references: Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1536-43
references: 16863930
references: Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):468-75
references: 20864273
references: Neurosurgery. 1999 Dec;45(6):1442-53
references: 10598712
references: Neuro Oncol. 2011 Dec;13(12):1331-8
references: 21896554
references: FASEB J. 2004 Feb;18(2):338-40
references: 14657001
references: J Clin Oncol. 2004 Jan 1;22(1):133-42
references: 14638850
references: Int J Cancer. 2007 Dec 15;121(12):2606-14
references: 17691110
references: Cancer Res. 2000 Apr 15;60(8):2178-89
references: 10786682
references: Int J Hematol. 2000 Jul;72(1):12-9
references: 10979203
references: Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):927-31
references: 14967452
references: Oncogene. 2005 Aug 18;24(35):5414-22
references: 15940265
references: J Clin Oncol. 2011 Jan 10;29(2):142-8
references: 21135282
references: J Exp Clin Cancer Res. 2012 Apr 26;31:37
references: 22538017
references: Neuro Oncol. 2011 Dec;13(12):1324-30
references: 21954442
references: J Neurooncol. 2008 May;88(1):1-9
references: 18228115
references: Oncogene. 2012 Sep 6;31(36):4054-66
references: 22139077
references: Neuro Oncol. 2011 Mar;13(3):290-7
references: 21292687
references: Cancer Chemother Pharmacol. 2002 Jan;49(1):69-77
references: 11855754
references: Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2264-71
references: 16609043
references: Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1518-26
references: 19906497
references: J Clin Oncol. 2011 May 20;29(15):2004-10
references: 21464401
references: J Neurooncol. 2005 Sep;74(2):99-103
references: 16193379
references: Radiat Oncol. 2012 Feb 22;7:25
references: 22356893
references: Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1537-45
references: 20338480
references: Cancer Res. 2010 Oct 1;70(19):7591-9
references: 20841470
references: Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1372-80
references: 18355978
references: Lancet Oncol. 2012 Sep;13(9):897-905
references: 22898678
references: J Biol Chem. 1997 Jan 31;272(5):2927-35
references: 9006938
references: Clin Cancer Res. 2004 Dec 15;10(24):8587-93
references: 15623642
references: Clin Cancer Res. 2010 Nov 15;16(22):5573-80
references: 20921209
references: Expert Rev Anticancer Ther. 2004 Apr;4(2):321-7
references: 15056061
references: Genes Dev. 2002 Jun 15;16(12):1472-87
references: 12080086
references: Biochem J. 1993 Apr 15;291 ( Pt 2):329-43
references: 8484714
references: Mol Cancer Ther. 2010 Apr;9(4):953-62
references: 20371721
references: Semin Radiat Oncol. 2002 Jul;12(3 Suppl 2):21-6
references: 12174341
references: J Neurooncol. 2012 Jan;106(1):147-53
references: 21739168
references: J Biol Chem. 2006 Dec 1;281(48):36883-90
references: 17005556
references: Cancer J. 2002 Jan-Feb;8(1):47-54
references: 11895203
references: Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1192-9
references: 16626884
references: Curr Neurol Neurosci Rep. 2012 Jun;12(3):294-301
references: 22544507
references: Cancer Res. 2005 Feb 1;65(3):671-80
references: 15705858
references: Invest New Drugs. 2012 Apr;30(2):749-57
references: 21049281
references: Int J Cancer. 2009 Jun 1;124(11):2719-27
references: 19199360
references: J Clin Oncol. 2011 May 20;29(15):1997-2003
references: 21464406
references: J Hepatol. 2012 May;56(5):1097-1103
references: 22245891
references: Nat Rev Cancer. 2002 Feb;2(2):91-100
references: 12635172
references: J Clin Oncol. 2009 Feb 10;27(5):740-5
references: 19114704
references: Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1526-37
references: 17234361
references: Anticancer Drugs. 2012 Nov;23(10):1016-21
references: 22932130
references: J Neurooncol. 2013 Mar;112(1):133-9
references: 23314822
references: Crit Rev Oncol Hematol. 1995 Jul;19(3):183-232
references: 7612182
references: Cancer Res. 2005 Aug 15;65(16):7462-9
references: 16103100
references: Ann Neurol. 2007 Feb;61(2):153-61
references: 17212356
references: J Clin Oncol. 2005 Aug 10;23(23):5294-304
references: 15998902
references: Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):836-41
references: 16751064
references: Int J Cancer. 2008 Jul 15;123(2):357-364
references: 18464290
references: Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):636-42
references: 22765876
references: Clin Cancer Res. 2011 Jun 15;17(12):4119-24
references: 21531816
references: Mol Cancer Ther. 2005 Nov;4(11):1670-80
references: 16275988
references: J Med Chem. 2002 Feb 28;45(5):1045-51
references: 11855984
references: Radiat Res. 2007 Jul;168(1):125-33
references: 17722999
references: Cancer. 2012 Nov 15;118(22):5601-7
references: 22517399
references: Cancer Res. 2009 Sep 1;69(17):6889-98
references: 19690143
references: Eur J Cancer. 2001 Sep;37 Suppl 4:S3-8
references: 11597398
references: Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):347-53
references: 20510539
references: Neurosurg Focus. 2006 Apr 15;20(4):E1
references: 16709014
references: Clin Cancer Res. 2012 Jul 15;18(14):3722-30
references: 22665903
references: Cancer Res. 2002 Dec 15;62(24):7291-7
references: 12499272
references: J Clin Oncol. 2010 Nov 1;28(31):4762-8
references: 20921456
references: Nat Rev Cancer. 2010 Jan;10(1):9-22
references: 20029421
references: Radiat Res. 2009 Nov;172(5):584-91
references: 19883226
references: J Clin Oncol. 2012 Apr 1;30(10):1114-21
references: 22370318
references: Nat Med. 2004 Feb;10(2):145-7
references: 14745444
references: Cancer Res. 2005 Apr 15;65(8):3328-35
references: 15833866
references: Lancet Oncol. 2010 Jun;11(6):521-9
references: 20493771
references: Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):383-9
references: 18793954
references: Neuro Oncol. 2010 Jun;12(6):608-13
references: 20156802
references: Cancer Res. 1997 Oct 15;57(20):4593-9
references: 9377574
references: Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):410-8
references: 11567815
references: J Med Chem. 2002 Mar 14;45(6):1300-12
references: 11881999
references: J Clin Oncol. 2008 Dec 1;26(34):5603-9
references: 18955445
references: Cancer Res. 1996 Sep 1;56(17):4032-9
references: 8752175
references: Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):58-66
references: 21036490
references: Cancer Chemother Pharmacol. 2008 Feb;61(2):179-88
references: 17393165
references: J Neuroimmunol. 1995 Mar;57(1-2):143-53
references: 7535788
references: Clin Cancer Res. 2003 Apr;9(4):1546-56
references: 12684431
references: Cancer Res. 1999 Sep 1;59(17):4413-8
references: 10485491
references: J Neurooncol. 2010 May;98(1):93-9
references: 19960228
references: J Clin Oncol. 2009 Mar 10;27(8):1268-74
references: 19204207
references: J Clin Oncol. 2007 May 1;25(13):1651-7
references: 17470857
references: Cancer Res. 2001 Mar 15;61(6):2413-9
references: 11289107
references: N Engl J Med. 2007 Jan 11;356(2):125-34
references: 17215530
references: Clin Cancer Res. 2010 Sep 1;16(17):4325-30
references: 20622047
references: Cancer Res. 1990 Sep 15;50(18):6039-44
references: 2393868
references: Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):321-8
references: 22687197
references: Blood. 2001 Jul 15;98(2):428-35
references: 11435313
references: Clin Cancer Res. 2005 Aug 1;11(15):5639-44
references: 16061883
references: Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):156-63
references: 19167838
references: Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1206-11
references: 23182702
references: Lancet. 2008 Nov 22;372(9652):1809-18
references: 19027483
references: Br J Cancer. 2001 Dec 14;85(12):2010-6
references: 11747347
references: Eur J Cancer. 2010 Jan;46(2):348-54
references: 19945857
references: J Med Chem. 1999 Aug 12;42(16):3033-40
references: 10447947
references: Eur J Cancer. 2010 Dec;46(18):3287-93
references: 20708924
references: Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):51-7
references: 21035955
references: N Engl J Med. 2005 Mar 10;352(10):987-96
references: 15758009
references: Cancer Res. 2000 Oct 1;60(19):5565-70
references: 11034104
references: Methods Enzymol. 2006;407:597-612
references: 16757355
references: Expert Opin Investig Drugs. 2001 Dec;10(12):2117-40
references: 11772309
references: J Neuropathol Exp Neurol. 1996 Nov;55(11):1143-9
references: 8939197
references: Clin Cancer Res. 2005 Feb 15;11(4):1462-6
references: 15746047
references: Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):67-76
references: 21030162
references: Chin J Cancer. 2013 May;32(5):253-65
references: 23642907